{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"groups":[{"description":"All patients that received Basiliximab 20 mg monoclonal therapy","id":"OG000","title":"Basiliximab 20 mg"}],"paramType":"NUMBER","populationDescription":"ITT population. All patient that received study drug","timeFrame":"until 30 days after stem cell transplant","title":"Number of Patients Engrafting at Day +30 by Short Tandem Repeat (STR) on Peripheral Blood Mononuclear Cells (PBMC's).","type":"SECONDARY","unitOfMeasure":"participants"}